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Objectives: The recent emergence of new psychoactive compounds (NPS) has raised 
prominent challenges in the fields of drug policy, substance use research, public 
health and service provision. The Recreational Drugs European Network (ReDNet) 
project, funded by the European Commission, was implemented to improve the 
information stream to young people and professionals about effects/risks of NPS 
identifying online products and disseminating relevant information through 
technological tools. 
Methods: Regular multilingual qualitative assessments of websites, drugs fora and 
other online resources were carried out using the Google search engine in 8 languages 
from collaborating countries. These included: the UK, Norway, Belgium, Germany, 
Hungary, Poland, Italy and Spain. Products were tested and prevention messages were 
developed and disseminated via technological tools such as interactive websites, SMS 
alert, social networking (Facebook, Twitter), Multimedia (You Tube), Smartphone 
applications (iPhone), and virtual learning environments (Second Life).   
Results: The ReDNet project established itself as the first Europe-wide prevention 
programme designed for NPS based on the efficacy of novel ICT-based forms of 
intervention. More than 650 NPS products and combinations were identified; relevant 
information was disseminated to target population and advice was given to both EU/ 
international agencies and national policy makers.   
Conclusions: Web monitoring activities are essential for mapping the diffusion of 
NPS and the use of technological tools can be successfully incorporated in specific 
prevention programmes. Furthermore, the involvement of multi-disciplinary 
international partnerships was and continues to be fundamental for responding to such 
a prominent challenge. 
  
INTRODUCTION 
Novel psychoactive substances (NPS) comprise an increasing number of ‘designer’, 
pharmaceutical and herbal drugs, often advertised and sold as ‘legal’ alternatives to 
illicit drugs (Corazza et al. 2011). This new phenomenon represents an unprecedented 
challenge in the field of drug addiction, but also a fast growing problem from social, 
cultural, legal and political perspectives (Schifano et al 2006; Sigismondi et al 2012). 
During 2012, 57 psychoactive substances were officially notified for the first time in 
the European Union, with the EU's early warning system reporting the appearance of 
more than one new psychoactive drug on the market every week (EMCDDA 2012). 
NPS are usually sold online through an amount of unregulated websites and are 
almost unknown to health professionals who may not be technically up to 
date/conversant, given the typical absence of up-to-date scientific literature and 
reliable sources of information (CASA 2008; Forman et al. 2006; Littlejohn et al. 
2005). 
In the last nine years, three European Commission-funded projects (the Psychonaut 
Web Mapping System I & II, www.psychonautproject.eu; and the ReDNet; 
www.rednetproject.eu) have identified over 650 NPS and combinations. These 
included a range of piperazines, synthetic cathinones, synthetic cannabimimetics, 
phenethylamines, aminoindanes, tryptamines, benzofuranes, various herbal/ethno-
drugs and a number of hallucinogenic compounds (Deluca et al. 2012; Corazza et al. 
2012). More specifically, the Recreational Drugs European Network (ReDNet), a 
multi-site project with 10 research centres across the EU, which was launched in 
April 2010 and ended in June 2012, aimed to: (a) develop accurate information on 
NPS, (b) pilot innovative and effective ICTs to disseminate this information, (c) 
assess the feasibility of different ICTs and the relevance of the information being 
disseminated to the target groups, and (d) inform future research in e-Health, selective 
prevention, and harm reduction. The project was cleared for ethical approval by the 
School of Pharmacy Ethics Committee, University of Hatfield, UK (15 December 
2010; PHAEC/10-42). 
 
METHODS 
The ReDNet methodology was articulated in three main parts: 
 
1) Web monitoring/ content development and online survey  
Regular monitoring of the web (i.e., websites, chatrooms, newgroups, fora, 
YouTube) was carried out. A range of generic Google search queries, with terms 
such as ‘legal highs’, ‘herbal highs’, ‘smart drugs’, and ‘research chemicals’, were 
formulated in 8 languages (e.g. English, Finnish, Norwegian, Dutch, Italian, 
German, Spanish, and Swedish). At the same time, a multilingual review of the 
available peer-reviewed literature, covering multimedia approaches for primary and 
secondary drug preventions, was carried out. This also included the analysis of  ‘non-
conventional, fugitive and ephemeral publications’, also known as ‘grey literature’ 
(Alberani, 1990). 
In addition, groups of both young people (secondary schools/college/universities) and 
health professionals were surveyed internationally about their a) levels of knowledge 
and awareness b) source and methods of distribution of reliable information about 
novel compounds in order to provide an initial evidence base to support key 
stakeholders in their efforts to enhance innovative solutions as a response to the 
rapid and unpredictable diffusion of NPS. Finally, the above data were used to 
inform fact-sheets, technical reports, scientific publications and other project-
related material 
2) Testing  
A range of testing activities focusing on a number of NPS products purchased from 
the web was carried out to investigate the content of the allegedly psychoactive 
products. The testing was made to match the products content against their ‘Label 
Claim’. In this respect, four questions needed to be investigated: 
 Does the product contain the substance stated on the ‘Label Claim’?  
 If yes, what amount does it contain? 
 Does it contain any other substances? 
 If no, what does it contain? 
Consequently, classical analytical techniques as well as modern non-destructive 
mobile techniques were utilized. The classical analytical techniques included: UV/ 
Vis spectroscopy, high-performance liquid chromatography, gas chromatography- 
mass spectrometry and nuclear magnetic resonance. These required destruction of the 
product to be tested by dissolving it in a suitable solvent. However, they gave high 
sensitivity of analysis and thus could detect drugs present in NPS products in minute 
amounts. On the other hand, modern non-destructive techniques measured the sample 
‘as received’ and did not require any sample treatment or destruction. These included: 
Attenuated total reflectance Fourier transform-infrared, near-infrared and Raman 
spectroscopies and were available as both laboratory based and handheld 
instrumentation. The handheld instrumentation offered the advantage of rapid, on-spot 
and mobile technology; thus, saved time and money from importing the sample to the 
laboratory. However, the identification was limited to substances present in the 
instrumental library. In addition, these techniques were less sensitive than classical 
analytical techniques as they only identified substances present in high amounts in a 
product. 
 3) Disseminating the relevant information via ICT tools 
A number of innovative ICT tools were developed to disseminate up-to-date and non-
judgmental information for young people and professionals. These included: (a) 
Interactive websites, where health professionals could register and receive access to 
reports and technical folders; (b) Social networking (Facebook, Twitter), where drug 
threads, videos and meetings could be posted targeting at risk populations, e.g.  young 
people; (c) SMS - Email Alerts (SMAIL), which may be seen as an innovative tool 
used to alert health professionals and increase awareness on NPS; (d) Multimedia 
tools, such as YouTube videos and virtual learning environments (e.g. Second Life 
events), which were implemented to facilitate fast dissemination of information 
relating to a range of NPS.     
 
RESULTS 
 
Over 650 substances were identified, including 179 phenethylamines/MDMA-like 
drugs, 220 synthetic cannabimimetics (e.g.: Spice drugs), 30 cathinones (e.g: 
Mephedrone, MDPV), 64 tryptamine classical derivates and 5 new derivates (e.g.: 5-
meo-DALT), 126 psychedelic phenethylamines from the Shulgin Index (Shulgin et 
al., 2011), 3 GHB-like drugs (e.g.: GBL, 1,4 BD), 5 PCP-like drugs (e.g.: PCE, 
methoxetamine), two piperazine, six herb/plants (e.g.: Salvia divinorum, Mytragina 
speciosa -Kratom), ten prescribing/non prescribing medicinal products 
(opiates/opiods,  antiseptics, anticonvulsants, benzodiazepines, stimulants, 
antiparkinsonian) and an increasing number of PIEDs (Performance Imagine 
Enhancing Drugs).  
A dedicated ReDNet online database was developed using a secured server. This 
database enabled the project partners to collaboratively contribute to the production of 
the index NPS technical reports, which were made accessible via both mobile 
technology and standard desktop devices. Results from Europe-wide survey among 
young people and health professionals are still in the statistical analysis phase. The 
total sample size was 3.551. Preliminary data from the young people group showed 
that one out of five (n=168, 21%) respondents did not have access to information about 
NPS. Over half the sample (n=558, 69%) reported it to be either ‘good’ or ‘very good’, 
and further 123 (15%) participants reported it was ‘average’. However, a considerable 
proportion of the sample (n=126, 16%) reported that their knowledge of NPS was either 
‘basic’ or ‘poor’. The following information is rated as important or very important: 
desired psychoactive effects (n=782, 97%), side effects (n=719, 88%) and key 
points/overview of NPS (n=679, 83%). Surprisingly, a significant proportion of 
respondents did not consider online marketing strategies (n=455, 56%), price (n=451, 
55%) or appearance (n=431, 53%) to be important information. Always, according to 
the young people the following methods of delivery were favoured for the distribution 
of information: email (n=205, 68%), dedicated website (n=158, 53%) and e-newsletter 
(n=52, 17%).  Preliminary data from the health professionals group showed that a 
majority (n=130, 74%) of respondents reported that their knowledge of NPS was either 
‘average’ or ‘good’. Always according to health professionals, the following information 
were perceived as important or very important: key points/overview of NPS (n=159, 
90%), reported adverse effects (n=156, 89%) and desired psychoactive effects (n=153, 
87%). Finally, the following methods of delivery were favoured for the dissemination of 
information by professionals: email (n=133, 76%), e-newsletter (n=70, 40%) and 
dedicated website (n=54, 31%). Social networking sites (n=14, 8%), sms (n=9, 5%) and 
conferences (n=1, 1%) were the least preferred methods of delivery. 
 Overall, the ReDNet has produced some 183 NPS technical reports, whose access was 
made restricted to the project partners only. A selection of 11 technical reports and 30 
factsheets was made publicly available on the project website and distributed via 
SMAIL (SMS and EMAIL information Service).  
 
Testing  
In order to inspect the content of the NPS products, reference libraries of standards 
commonly present in NPS products were created using both the classical and non-
destructive techniques.  
The classical techniques identified the major substance(s) present in NPS products as 
well as separating them (Assi et al. 2011a, Assi et al. 2012a). Caffeine was the major 
impurity found in the products purchased so far and was present in more than 60% of 
these products. 
In case of spectroscopic techniques, the libraries were created using laboratory-based 
instruments and transferred to handheld instruments so they could be used in the field 
(Assi et al. 2011b; Assi et al. 2011c; Assi et al. 2011d; Assi et al. 2012b). Following 
this, the Internet test products were compared against these libraries. Figure 1 shows 
the results’ sheet of an NPS product tested using a handheld spectroscopic instrument. 
The spectroscopic techniques were additionally utilized to investigate the 
physicochemical properties of these NPS products when used with the suitable 
chemometric techniques. The chemometric techniques involved multivariate 
classification and regression (such as principal component analysis and regression) 
techniques in order to investigate/ identify differences among products.  
Although the products were advertised as of high purity, they were often 
contaminated by other impurities, which could be pharmacologically active (e.g. 
caffeine) or not. Other impurities included anaesthetics (lidocaine), anti-emetics 
(domperidone) or even inactive substances (lactose). 
 
Disseminating relevant information via ICT tools 
An interactive project website was created (www.rednetproject.eu) representing the 
main medium by which results and news associated with the project were 
disseminated. The main page was translated into all languages covered by the project 
partners and was embedded with a number of multimedia features, including an 
internal database (wikiserver) for project partners, links to social networking 
applications, downloads, contribute function and links to the range of project 
activities. By June 2012, the number of visitors (per month/last month) was 1,176, 
with an average value of over 1,000 for the last six months of the project. Overall, the 
website has been visited by 16,567 people, with 998 people having registered on the 
mailing list. 
 
Facebook 
A project page on Facebook was launched in April 2010 and was kept updated with 
regular posts on various substance misuse issues as well project activity updates. By 
June 2012, it counted 400 ‘likes’ from individuals from 20 different countries 
including the USA, Australia and Costa Rica. Typical users were females (52%) in 
the age range 25-34 years old. 
 
SMS - EMAIL information Service (SMAIL; www.rednetproject.eu/smail) 
Over the past 10 years, the technology of mobile phones operates as digital assistants, 
email platforms and time schedulers. Therefore, the ReDNet project developed an 
integrated and free SMS-Email system, called SMAIL (SMS and EMAIL information 
Service)  designed to a) send automatically an SMS with descriptive key points for 
unknown compounds texted both as nicknames or chemical names by health 
professionals b) generate instantly an email with the available and reliable 
information (in form of electronic fact sheets) on novel compounds requested c) 
receive regular invitations to NPS-related events/ meetings d) inform directly the 
ReDNet research team about novel trends in drug abuse. The SMAIL system has 
started in May 2012, recruiting over 100 European subscribers in only two months, 
providing a starting number of 20 factsheets and 217 drug search (Figure 2). 
The effectiveness of the SMAIL service was tested by sending text messages to the 
subscribers for evaluation on a scale of 1 to 5; such that 1 is very effective and 5 was 
not effective. High response profile was obtained and it was shown that 61% of the 
subscribers scored 1 (Figure 3); whereas only 8% ranked it as non-effective. 
 
Multimedia tools  
Videos for You Tube/Art Communication project 
The direct involvement of young people was sought for the preparation of various 
educational video-clips to be distributed via both You Tube and the ReDNet website.  
An Art Communication competition was organized among a group of 72 students (18-
24 years old) at both the Film and Media Department at the University of 
Hertfordshire and the Marche Region Academy of Arts (Accademia di Belle Arti of 
Macerata, Italy), in collaboration with the ‘Stammibene’ project. The videos, in 
English and Italian languages, were uploaded to a dedicated ReDNet Art 
Communication website (www.clipshow.info), which was launched in February 2012. 
Since then, the website has recorded 2,345 visits. Works were also disseminated via 
You Tube, Facebook, the website project (www.rednetproject.eu), and related 
websites (www.regione.marche.it).   
 
Virtual Seminars in Second Life 
A ReDNet seminar room was developed and launched in January 2011 in the virtual 
world of Second Life (SL) as a cost-effectiveness multimedia approach. Seven events 
took place throughout the duration of the project. These involved the participation of 
professionals internationally and various experts were invited to present issues on 
clinical, social and legal challenges posed by the rapid diffusion of novel 
psychoactive substances. This was an opportunity a) to find out more about the new 
products on the market b) to present a cost effective solution for international 
networking and partnership c) to pilot the efficacy and accessibility of virtual learning 
environments. Table 2 shows a list of the ReDNet seminars in Second Life. 
 
Table 2. 
 
CONCLUSIONS 
The rapid diffusion of NPS is a cross-national challenge. This justifies the need for 
international networks of excellence such as ReDNet. During its 27 months of 
activity, the ReDNet project was able to establish itself as the first EU-wide ICT-
based preventative programme designed for NPS targeted at both the young and the 
professionals working with them. Despite the challenge, it was able play a strategic 
role in providing multidisciplinary advice to both EU/international agencies and 
national policy makers such as European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), United Nation on Drugs and Crime (UNODC), a range of EU 
national Anti-drug departments, advisory boards, charities and drug organizations 
across the EU.  
In addition, the Centre for Clinical Practice, Safe Medicine and Drug Misuse 
Research at the School of Pharmacy at the UH, was licenced by the UK Home Office 
to carry out chemical analysis and testing of a variety of new designer drugs.  
Initiatives such the First International Conference on Novel Psychoactive Substances 
launched by ReDNet and the EMCDDA in Budapest 2012 
(https://www.rednetproject.eu/conference/) are essential to spread scientific 
knowledge and reliable and multidisciplinary information as widely as possible.  
The ReDNet project emphasized the importance of drug prevention through online 
tools appealing to young people (Facebook, Twitter, You Tube amongst others). 
Prevention strategies should include evidence-based public health messages to 
users/potential users distributed via ICT tools as most the NPS are sold online through 
the same mediums. In addition, an ICT-based model of prevention is a cost-effective 
and environmental friendly model of prevention. In addition, it explored the potential 
on Internet monitoring as an essential phase to identify new emerging trends and 
products of abuse. A possible limitation of the present study could be given by the 
fact that only publicly available websites, fora and similar sources were 
monitored. Conversely, to improve the coverage of the study not only the web 
pages but also more private ways of communication (including newsgroups, 
chatrooms, mailing lists, e-newsletters, and bulletin boards) were here 
considered.  
Overall the strength, experience and multidisciplinary resources of the network, and 
the internal resources of the partners by way of research attachments, will support the 
project sustainability and allow the ReDNet project to have a durable impact on 
European and international research after the end of EC co-funding (2012). 
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FIGURES 
 
Figure 1 Results sheet showing the spectra of pure dextromethorphan hydrobromide 
which was matched against the reference substance in the instrument library using the 
Thermo Truscan handheld Raman instrument. 
  
  
Figure 2 Number of users, regions, professions, phone types, factsheets and drug 
search evaluated for the SMAIL service over a period of two months. 
 
 
 
 
Figure 3 Effectiveness ranking of the subscribers for the SMAIL service. A score of 1 
shows high effectiveness and 5 no effectiveness. 
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Table 1 List of speakers and seminars available in second life 
 
Date Discipline Number 
of 
attendees 
Number 
of 
countries 
Speaker Speaker profile Topic 
26/01/2011 Drugs and 
Legislation 
27 6 Pasquale 
Policastro 
Professor of Constitutional Law 
and European Integration,  
Faculty of Law and 
Administration, University of 
Szczecin, Poland 
Promoting Active Life and 
Positive Attitude:  
Tasks, Methods and 
Proposal for New Drug 
Legislation 
29/03/2011 Neurobiological  
and clinical issue 
33 9 Fabrizio Schifano Professor, MD, MRCPsych, Dip  
Clin Pharmacology University of 
Hertfordshire, UK 
 Novel psychoactive 
substances:  
Neurobiological and clinical 
issues 
28/04/2011 Chemical testing 31 7 Sulaf Assi Doctor, Centre for Excellence for 
Practice, Medicine Safety 
and Drug Misuse, School of 
Pharmacy, University of 
Hertfordshire, UK 
Chemical Testing of 
Designer Drugs:  
New Techniques and 
Challenges 
28/06/2011 Neuro-scientific and  
socio-cultural issues 
20 5 Gilberto Gerra Doctor, Chief of Drug Prevention 
and  
Health Branch, Division for 
Operations, United Nations 
Office on Drugs and Crime 
(UNODC), Vienna, Austria 
Prevention of Abuse: 
lessons  
learned from neuroscience  
and socio-cultural research 
26/10/2011 Drug use prevention 25 11 Claudia Rimondo Project manager - Verona 
Addiction  
Department (Italy) 
Drug use prevention among  
young people:novel 
methods  
and materials 
30/11/2011 Web monitoring 27 10 Liv Holmefjord Consultant - Bergen Clinics 
Foundation  
Competence Centre, Norway 
Monitoring the new 
compounds on the web: an 
integrated component on 
the Bergen Earlier Warning 
System 
08/02/2012 Trends 22 7 Ulrik Solberg Msc, EMDDA, Lisbon, Portugal Drugs on the Internet: 
emerging trends in Europe 
 
